Nitric oxide is an endothelium-derived relaxing factor. Conversion of L-arginine to nitric oxide follows mediator-induced elevation of endothelial cytosolic calcium concentration. However, not all endothelium-dependent vasodilatation is caused by endothelium-derived relaxing factor, and few studies have correlated changes in vascular tone with measurement of free cytosolic calcium concentration or nitric oxide. The effects of three endothelium-dependent vasodilators (acetylcholine, bradykinin, and A23187) on vascular tone and nitric oxide production were studied in proximal rat pulmonary artery rings. Changes in free cytosolic calcium concentration and nitric oxide production were also studied in bovine pulmonary artery endothelial cells.
T he endothelium can mediate pulmonary vasodilatationl-4 by production of prostanoids, endothelium-derived relaxing factors (EDRFs), such as nitric oxide,5,6 and an endothelium-derived "hyperpolarizing factor" (EDHF). 7, 8 An apparently simple hemodynamic phenomenon may be the summation of a number of these endothelium-based mechanisms acting in concert. The relative contribution of these mechanisms to a vasodilator response may vary, depending on the dose of drug administered and the species and vascular bed studied.9-13 This complexity underscores the need to correlate hemodynamic changes with concurrent measurement of cell biochemistry. The few studies6'14-'7 that have correlated endothelium-dependent vasodilator-induced nitric oxide production with changes in vascular tone have been conducted on systemic vessels. In the lung, the identity and physiological importance of EDRF have primarily been evaluated through the use of EDRF inhibitors and bioassays, which are of varying specificity.1-4 '13,18-20 Such studies show sufficient discrepancies between the hemodynamic profiles of nitric oxide and the many endothelium-dependent vasodilators to cast doubt on the hypothesis that all endothelium-dependent pulmonary vasodilators act through a nitric oxide-dependent mechanism. For example, although bradykinin (BK) and acetylcholine (ACh) cause endothelium-dependent pulmonary vasodilatation in the lung,3 the potency, duration of action, and predisposition to tachyphylaxis of these agents differ from each other and from exogenous nitric oxide.3 NG-Monomethyl L-arginine (LNMMA), a competitive inhibitor of the conversion of L-arginine to nitric oxide, inhibits BK-but not ACh-induced pulmonary vasodilatation.2 Furthermore, Menon et a12' showed that A23187-but not AChinduced pulmonary vasodilatation was associated with nitric oxide synthesis in bovine pulmonary arteries. Since EDRF bioactivity is thought to be associated with a rise in endothelial free cytosolic calcium concentration22-24and the subsequent conversion of L-arginine to Circulation Research Vol 68, Vo 6 June 1991 nitric oxide,6 the current study examined the effects of three endothelium-dependent vasodilators (ACh, BK, and A23187) on these variables in cultured pulmonary artery (PA) endothelial cells and rat PA rings.
Materials and Methods Pulmonary Artery Ring Model
Adult, male, specific pathogen-free Sprague Dawley rats were anesthetized (50 mg/kg i.p. nembutol) and placed on a warming table. The rats were ventilated with humidified room air via a tracheotomy; a small animal ventilator (70 breaths/min, 3 ml tidal volume, 3 cm H20 positive end-expiratory pressure, Harvard Apparatus, South Natick, Mass.) was used. The lungs were exposed via thoracotomy, as previously described. 23 The second division of the right PA was dissected free with iris scissors, avoiding endothelial injury. In some experiments, the endothelium was removed by gentle rubbing with a metal probe. Scanning electron micrographs of representative rings were obtained to document the efficacy of this technique ( Figure 5 ). Rings were mounted on stainless-steel wires attached to force-displacement transducers (model UC-2, Grass Instrument Co., Quincy, Mass.) and suspended in a 75-ml bath containing Earle's solution (pH 7.430+0.001; temperature, 37.5+0.1°C; Po2, 130-140 mm Hg). The rings (two rings per bath) were held 1 cm apart, and nitric oxide samples were withdrawn from midway between vessels using a 1-ml gas-tight syringe. Rings were allowed to equilibrate for 30 minutes and then maintained at a resting tension of 800 mg.
After equilibration, each vessel was constricted with norepinephrine (3.1 x 10 M). Once the constriction had plateaued, the rings were given either BK (10'-1o-6 M, n=12), ACh (10-6_10-5 M, n=10), or A23187 (10-6 M, n=12 (Figures 2-4) . The bath was then flushed clean. Once PA tension had reequilibrated, superoxide dismutase (SOD) was given (2,000 units, bovine SOD, Sigma), and after 10 minutes, rings were constricted with norepinephrine. When the norepinephrine constriction had plateaued, the rings were exposed to the same doses of the same dilator they had received before SOD administration. Nitric oxide samples were drawn before and after administration of SOD, norepinephrine, and each of the three vasodilators (Figures 2-4 ing. Figure 1 ). Nitric oxide given in a saline solution at 40-and 80-pmol doses caused a chemiluminescence signal that was similar in magnitude to that produced by an equivalent dose of gaseous nitric oxide ( Figure  1 ). This indicated that the stripping of nitric oxide from solution was effective in mobilizing dissolved nitric oxide into the gaseous phase (Figure 1 ). Nitrogen gas, solutions of sodium nitrite (1 mM), and potassium nitrate (1 mM) failed to cause any chemiluminescence signal.
Pulmonary Artery Rings
ACh caused the most vasodilation of the three drugs ( Figure 2 ). A23187 resulted in an intermediate degree of dilation (Figure 3) , whereas BK caused only minor vasodilation of norepinephrine-constricted PA rings (Figure 4) . SOD did not alter the vasodilation caused by A23187 (-12+3% both before and after SOD) (Figure 3) . Neither did it enhance BK-induced vasodilatation (-11+3% before SOD and 6+2% after SOD) (Figure 4 ). ACh not only caused a greater degree of pulmonary vasodilation than did BK or A23187 (-51±4% before SOD, p<0.01), but this vasodilation was enhanced by SOD (-94+4% vasodilation after SOD; p<0.01 value differs from BK or A23187 group) (Figure 2 ).
The magnitude of the norepinephrine-induced constrictions was not altered by SOD and was similar among the three groups (Figures 2-4 Scanning electron micrographs comparing luminal surfaces in denuded versus intact rings confirmed that the denuded rings were devoid of endothelial lining ( Figure 5 ). There was also no nitric oxide production by the denuded rings at baseline or in response to A23187 (10-6 M). ATA23187 (the reduction in PA ring tension ahieved by A23187/plateau tension before A23187) x 100.
Nitric Oxide Production by Pulmonaty Artery Rings and Endothelial Cells
There was no basal nitric oxide production detected (Figures 2-4) . Only A23187 consistently caused detectable nitric oxide production in the absence of SOD (Figure 3 ). The magnitude of the A23187-induced nitric oxide signal was greatly enhanced by SOD pretreatment (Figure 3) . BK also caused a small, but consistent, nitric oxide signal when rings were pretreated with SOD. ACh failed to cause detectable nitric oxide production even in the presence of SOD.
Without SOD, only two of 12 attempts to detect nitric oxide production from A23 187-stimulated beads were successful, whereas two of four experiments in which beads were pretreated with SOD resulted in a signal of > 1-2 mV. ACh and BK failed to cause a detectable nitric oxide signal when administered to the endothelial cell-coated beads.
Cytosolic Calcium
The administration of physiological levels of calcium to the cultured PA endothelial cells (which had been in calcium-free media during the fura loading) resulted in a rapid rise in cytosolic calcium, followed by a decline, over 5 minutes, to a stable plateau level ( Figure 6 ). (Figure 7) , the higher doses occasionally resulted in marked elevation of cytosolic calcium levels. Atropine lowered cytosolic calcium and reduced the fall in cytosolic calcium concentration caused by ACh (Figure 8 ). A23187 and BK both increased the free cytosolic calcium concentration (Figures 7 and 9 ). Ca2+, the absolute free cytosolic calcium concentration achieved in the calcium-deficient media was less ( Figure 9 ). ACh tended to increase intracellular calcium concentration in calcium-free media ( Figure 9 ). A23187 (10 8 M) increased free cytosolic calcium concentration in cells studied in the calcium-free state to a similar extent as when the drug was given in the presence of extracellular calcium ( Figure 9 ). Discussion Endothelium-dependent pulmonary vasodilatation caused by A23187 and BK was associated with nitric oxide synthesis (Figures 2-4) 10 Menon et a121 provided the first direct evidence that ACh did not cause nitric oxide synthesis in the pulmonary vasculature. They reported that A23187, but not ACh, caused nitric oxide production from bovine pulmonary arteries. Since the endothelium can mediate pulmonary vasodilatation by several nitric oxideindependent mechanisms, including production of prostanoids and EDHF,7,8 correlation of nitric oxide production with vasodilation is essential to differentiate among mechanisms.
A23187 and BK, but Not ACh, Stimulated Nitric
Oxide Synthesis In the current study, nitric oxide became detectable 15-30 seconds after administration of A23187 or BK. This nitric oxide was proven to originate in the endothelium, since A23187 administration did not stimulate nitric oxide synthesis when given to denuded rings, even in the presence of SOD. Denuded rings displayed a loss of the typical "cobblestone" appearance of the luminal surface on scanning electron microscopy ( Figure 5 ). They also failed to dilate in response to ACh.
The few direct demonstrations that ACh can elicit nitric oxide synthesis have been performed in systemic vessels and used chemiluminescence assays that acidified the specimen in the presence of potassium iodide.14'15"7 The failure of ACh to elicit nitric oxide synthesis in the lung could be due to differences between pulmonary and systemic vessels; certainly the pulmonary vasculature differs from most systemic circulations in its response to hypoxia (constriction instead of dilatation). Alternatively, apparent differences in the effects of ACh on nitric oxide synthesis between the circulations might result from the types of chemiluminescence assays used. The absence of the acidification step in the current assay (made possible by the exclusion of 02 from the assay) greatly enhances the specificity of the technique, largely by preventing nitroso compounds, nitrites, and nitrates from being converted to nitric oxide during measurement. 28 The current study and that of Menon et a"21 are the only two that have evaluated the effects of ACh on nitric oxide production in the pulmonary circulation using a nonacidified chemiluminescence technique; both failed to detect AChinduced nitric oxide synthesis.
ACh-induced vasodilatation was partially inhibited by the cyclooxygenase blocker meclofenamate. This presumably represents the inhibition of production of ACh-induced prostacyclin synthesis. Meclofenamate, at doses that significantly inhibited ACh-induced prostaglandin synthesis, failed to prevent the early and preponderant dilator response to ACh in the isolated rat lung.3'29 It is unlikely that AChinduced vasodilation resulted from nitric oxide production at levels below the detection threshold of the current assay, since the much weaker vasodilation elicited by BK and A23187 caused measurable nitric oxide synthesis. The fact that ACh was a more potent pulmonary vasodilator than either BK or A23187 suggests that the mechanism used by ACh may be a more important determinant of pulmonary vascular tone than the nitric oxide pathway. The pulmonary vasodilation by producing EDHF (or otherwise hyperpolarizing the vascular smooth muscle) will require direct measurement of membrane potential and assessment of the effects of the ACh-PA endothelial cell interaction on the activity of smooth muscle K' channels via patch-clamping. SOD Enhanced Detection of Nitric Oxide SOD enhanced the detection of nitric oxide. This is consistent with previous bioassay studies in which superoxide anion ( 02 ) shortened32 and SOD prolonged t112 of EDRF.33 SOD increased the size of the chemiluminescence signal in response to A23187, the most potent of the nitric oxide-producing agents. However, a signal was usually detectable even in the absence of SOD (Figure 3 ). This presumably reflects the ability of SOD to scavenge radicals produced by the PA ring, thus preventing these radicals from destroying nitric oxide. Previous studies34,35 have documented the physiological production of 02 radicals in the normoxic rat lung. BK only elicited detectable nitric oxide when rings had been pretreated with SOD ( Figure 4 ). This may reflect the ability of BK to stimulate radical production by increasing cyclooxygenase metabolism.12 If BK administration increased radical production, SOD might be required to stabilize the nitric oxide long enough to permit its diffusion into the perfusate, which is essential for its detection. ACh did not lead to nitric oxide production even in the presence of SOD, and yet ACh-induced pulmonary vasodilatation was enhanced by SOD ( Figure 2 ). This suggests that EDHF, or another intermediary in the as-yetundefined ACh vasodilation sequence, is sensitive to O0 and, like nitric oxide, is protected by the administration of SOD.
It is intriguing that SOD increased the magnitude of the nitric oxide signal produced in the perfusate around the PA rings by A23187 and BK and yet failed to enhance vasodilatation. This could mean that nitric oxide is only a marker for the "true" EDRF, which could be a related compound, such as a nitrothiol. Alternatively, the amount of nitric oxide that diffuses into the bath might not reflect the concentration of nitric oxide at the endothelial cellsmooth muscle junction. Since SOD is a large molecule and unable to enter the vascular wall rapidly, it may only protect nitric oxide that "leaks" from the endothelial cell. This would leave the more important "pool" of nitric oxide that is in direct contact with the smooth muscle cell susceptible to destruction by radicals. There was no basal release of nitric oxide detected even in the presence of SOD. This may reflect the true absence of basal production or indicate that the level of nitric oxide production in these small rings does not exceed the threshold for detection of this assay (10 pmol) 
